Loyens & Loeff advised Karo Pharma AB on Swiss aspects of the acquisition of all shares in Hygis SA
Hygis SA is a Swiss distributing company with exclusive distribution rights to Karo Pharma’s brands MultiGyn and MultiMam. This acquisition will further strengthen Karo Pharma’s direct presence in the DACH region.
Karo Pharma is a pharmaceutical company founded in 1987 specialized in sales and marketing of prescription pharmaceuticals and over-the-counter products sold in pharmacies and retail. Karo Pharma is listed on Nasdaq Stockholm Mid Cap.
Loyens & Loeff advised Karo Pharma in the transaction with a team led by Marco Toni and consisted of Fabian Sutter, Valérie Schrämli and Renate Loretan-Bührle.
Marco Toni
Partner Attorney at lawMarco Toni, attorney at law, is a partner in our Zurich office. He focuses on domestic and international M&A transactions, private equity, corporate governance and general corporate, stock exchange and capital markets laws.
T: +41434346700 E: [email protected]
Fabian Sutter
Partner Attorney at law, Swiss certified tax expertFabian Sutter, attorney at law and Swiss certified tax expert, is a partner in our Zurich office. He focusses on Swiss and international taxation, in particular corporate reorganizations and restructurings, M&A, financing and capital market transactions, transfer pricing, private equity, real estate transactions as well as tax litigation.
T: +41434346700 E: [email protected]
Valérie Schrämli
Associate Attorney at lawValérie, attorney at law, is an associate in our Zurich office and she focuses on domestic and cross-border M&A, private equity and capital market transactions, corporate governance, general corporate law and contractual matters.
T: +41434346700 E: [email protected]
